Lung cancer trials in Netherlands

In Netherlands 142 Also abroad 2747

142 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in Netherlands
In Vivo Fluorescence Molecular Bronchoscopy of Durvalumab-680LT in Patients With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) After Chemoradiotherapy
Where
Groningen
Age
18 years and over
People
20
Run by
University Medical Center Groningen
See details and how to joinNCT07653438 · EU 2026-526251-60-00
No phaseTaking people
Prospective Data Collection Initiative on Thoracic Malignancies
Where
Alkmaar, Amersfoort, Amsterdam, Breda, Delft, Deventer, Ede, Eindhoven, Enschede, Gouda, Groningen, Hilversum, Hoofddorp, Leeuwarden, Maastricht, Nijmegen, Rotterdam, Sittard, The Hague, Utrecht
Age
18 years and over
People
12,000
Run by
Dutch Society of Physicians for Pulmonology and Tuberculosis
See details and how to joinNCT06996249
Phase 1/2Taking people
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Where
Amsterdam, Nijmegen, Rotterdam
Age
18 years and over
People
180 worldwide
Run by
Alentis Therapeutics AG
See details and how to joinNCT07169734 · EU 2025-521441-24-00
Phase 2Taking people
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Where
Amsterdam
Age
18 years to 70 years
People
170 worldwide
Run by
Iovance Biotherapeutics, Inc.
See details and how to joinNCT04614103 · EU 2024-510778-26-00
No phaseTaking people
Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates
Where
Amsterdam
Age
18 years and over
People
30
Run by
Creo Medical Limited
See details and how to joinNCT06689488
Phase 1Taking people
Performance and prognostic value of 68Ga-FAPI PET/CT in non-small cell lung cancer (NSCLC)
Where
Amersfoort
Age
18 years and over
People
20
Run by
Meander Medisch Centrum
See details and how to join2023-503985-21-00
No phaseTaking people
Value of Screening MRI Brain in Stage IV Non-small Cell Lung Cancer
Where
Groningen, Maastricht, Scheemda
Age
18 years and over
People
100
Run by
University Medical Center Groningen
See details and how to joinNCT05864794
Phase 2Taking people
Boosting Osimertinib Blood Brain Barrier Penetration
Where
Amsterdam, Maastricht, Rotterdam
Age
18 years and over
People
7
Run by
Maastricht University Medical Center
See details and how to joinNCT07485452 · EU 2025-523033-26-00
Phase 2Not yet taking people in Netherlands
Phase II Study of Upfront SRT Plus Ivonescimab/Chemotherapy vs Ivonescimab/Chemotherapy in NSCLC Brain Mets
Where
Maastricht, Rotterdam, Utrecht
Age
18 years and over
People
158 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT07234877 · EU 2025-522985-60-00
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Amsterdam, Groningen
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
Phase 1Taking people
A study to test how BI 764532 is taken up by tumours in people with small-cell lung cancer or neuroendocrine cancer
Where
Amsterdam
Age
18 years and over
People
12
Run by
Boehringer Ingelheim International GmbH
See details and how to join2022-501818-54-00
Phase 1Taking people
Phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.
Where
Nijmegen, Utrecht
Age
18 years and over
People
76 worldwide
Run by
Novartis Pharma AG
See details and how to join2023-510356-23-00
No phaseTaking people
Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation
Where
Groningen
Age
18 years and over
People
10,000
Run by
University Medical Center Groningen
See details and how to joinNCT02421718
Phase 1Taking people
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Where
Amsterdam
Age
18 years and over
People
304 worldwide
Run by
AstraZeneca
See details and how to joinNCT04686305 · EU 2023-504949-31-00
No phaseTaking people
Confocal Laser Endomicroscopy VERification
Where
Amsterdam
Age
18 years and over
People
208 worldwide
Run by
Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)
See details and how to joinNCT06079970
Phase 1Taking people
Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
Where
Nijmegen, Rotterdam
Age
18 years and over
People
55 worldwide
Run by
DeuterOncology
See details and how to joinNCT05752552
Phase 2Not yet taking people in Netherlands
Feasibility of Fluorescence Imaging With Bevacizumab-800CW During Bronchoscopy
Where
Groningen
Age
18 years and over
People
20
Run by
University Medical Center Groningen
See details and how to joinNCT06809946 · EU 2024-510793-24-00
Phase 4Taking people
Increasing the dosing interval of osimertinib in patients with EGFR mutated locally advanced or meta-static non-small cell lung cancer - OSI-SAVE
Where
Amsterdam, Groningen, Leiden, Maastricht, Nijmegen, Rotterdam, Utrecht
Age
18 years and over
People
283 worldwide
Run by
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2024-514693-47-01
No phaseTaking people
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Where
Amsterdam, Deventer, Leeuwarden, Nijmegen, Utrecht
Age
18 years and over
People
8,000 worldwide
Run by
UMC Utrecht
See details and how to joinNCT04075305
Phase 1Taking people
Study Investigating Tucatinib and Osimertinib Pharmacokinetics in Primary and Metastatic Brain Tumors: the STICK trial
Where
Amsterdam
Age
18 years and over
People
20
Run by
Amsterdam UMC Stichting
See details and how to join2025-522128-28-00
Phase 2Not yet taking people in Netherlands
Improved baseline staging with 68Ga-FAPI-46 PET in non-small cell lung cancer – a pilot study
Where
Maastricht
Age
18 years and over
People
10
Run by
Academisch Ziekenhuis Maastricht
See details and how to join2025-523032-39-00
No phaseTaking people
IMPT Dose Escalation for NSCLC (HyDose)
Where
Groningen
Age
18 years and over
People
87
Run by
University Medical Center Groningen
See details and how to joinNCT06484491
Phase 2/3Not yet taking people in Netherlands
Test-Retest Evaluation of [18F]F-AraG in Lung Tumors (TREAT)
Where
Amsterdam
Age
18 years and over
People
7
Run by
Amsterdam UMC Stichting
See details and how to join2025-522404-24-01
Early phase 1Taking people
PET-imaging of Two Vartumabs in Patients With Solid Tumors
Where
Groningen
Age
18 years and over
People
32
Run by
Var2 Pharmaceuticals
See details and how to joinNCT06645808 · EU 2024-513827-18-00
Phase 3Not yet taking people in Netherlands
A phase III trial of a De-escalated Immune-strategy During first-line treAtment in patients with metastatic non-small Cell lung cancer (NSCLC): DIDaC
Where
Amsterdam, Apeldoorn, Dirksland, Dordrecht, Leiden, 's-Gravenhage
Age
18 years and over
People
500
Run by
Leids Universitair Medisch Centrum (LUMC)
See details and how to join2025-520792-67-00